Abstract | AIM: METHODS: The mouse UC model was developed using 5% dextran sulfate sodium. Mice were randomly divided into four groups: normal control, UC model group, resveratrol low-dose group (RLD; 50 mg/kg per day), and resveratrol high-dose group (RHD; 100 mg/kg per day). RESULTS: CONCLUSION: The therapeutic efficacy of resveratrol in UC is dose dependent and closely associated with the regulation of Treg/Th17 balance and the HIF-1α/mTOR signaling pathway.
|
Authors | Jun Yao, Cheng Wei, Jian-Yao Wang, Ru Zhang, Ying-Xue Li, Li-Sheng Wang |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 21
Issue 21
Pg. 6572-81
(Jun 07 2015)
ISSN: 2219-2840 [Electronic] United States |
PMID | 26074695
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Hif1a protein, mouse
- Hypoxia-Inducible Factor 1, alpha Subunit
- Inflammation Mediators
- STAT3 Transcription Factor
- Stat3 protein, mouse
- Stilbenes
- Dextran Sulfate
- mTOR protein, mouse
- TOR Serine-Threonine Kinases
- Resveratrol
|
Topics |
- Animals
- Colitis
(chemically induced, immunology, metabolism, pathology, prevention & control)
- Colon
(drug effects, immunology, metabolism, pathology)
- Cytokines
(metabolism)
- Dextran Sulfate
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Hypoxia-Inducible Factor 1, alpha Subunit
(metabolism)
- Inflammation Mediators
(metabolism)
- Male
- Mice, Inbred BALB C
- Resveratrol
- STAT3 Transcription Factor
(metabolism)
- Signal Transduction
(drug effects)
- Spleen
(drug effects, immunology, metabolism)
- Stilbenes
(pharmacology)
- T-Lymphocytes, Regulatory
(drug effects, immunology, metabolism)
- TOR Serine-Threonine Kinases
(metabolism)
- Th17 Cells
(drug effects, immunology, metabolism)
- Time Factors
|